Private Assets
Private Assets
Private Debt and Healthcare Private Equity
Private Debt: Tailored Support for Growing Companies
Montpensier Arbevel provides long-term support to French and European SMEs in their development through customized financing solutions, incorporating an ESG approach.
Objective: To support ambitious projects, whether for organic growth, strategic acquisitions, or ownership transitions.
The Arbevel Dette Privée PME I and II funds support SMEs with EBITDA exceeding €2 million, operating either independently or with partners. We offer innovative financing solutions guaranteed by the European Investment Fund (EIF)*.
These solutions, with maturities of 5 to 7 years and investment tickets ranging from €1.5 to €7.5 million, are accompanied by a rigorous ESG approach.
Private Equity: Investing in Innovations in the Healthcare Sector
Montpensier Arbevel engages in Private Equity with a focus on the healthcare sector, a critical area strengthened by long-term trends.
The Arbevel Life Sciences Crossover fund supports innovative companies in the sector by investing in equity and quasi-equity. This strategy aims to deliver sustainable performance while addressing major societal challenges.
By adopting a responsible approach, Montpensier Arbevel contributes to improving access to effective and sustainable healthcare solutions.
* The financing provided by the Arbevel Dette Privée PME I and II funds benefits from various guarantees from the European Investment Fund (EIF), supported by the European Union.